GlassScriptPhysician profile
Charles H Andrews
NPI 1750345955
$6,118.55
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $2,220 · 2021: $1,728 · 2022: $625.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,371.28 | 2019-2022 | |
| Pfizer INC. | $665.43 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $490.95 | 2019-2021 | |
| Lilly USA, LLC | $489.08 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.04 | 2019-2022 | |
| Amgen INC. | $436.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $286.16 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $267.71 | 2019-2022 | |
| Abbvie INC. | $229.48 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $189.68 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $153.22 | 2019-2020 | |
| Esperion Therapeutics, INC. | $132.41 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.05 | 2021 | |
| Allergan, INC. | $124.61 | 2019-2020 | |
| Amarin Pharma, INC. | $110.72 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $101.53 | 2020-2022 | |
| Eisai INC. | $66.87 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $56.88 | 2019-2021 | |
| Astellas Pharma US INC | $56.70 | 2019-2020 | |
| Genentech USA, INC. | $46.74 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $37.52 | 2019-2021 | |
| Sanofi Pasteur INC. | $36.27 | 2019-2022 | |
| Radius Health, INC. | $32.64 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $31.46 | 2019 | |
| Alfasigma USA, INC. | $31.36 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $25.73 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.27 | 2022 | |
| Assertio Therapeutics, INC. | $16.77 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.